|
SPTY2D1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.44250000225321E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.28579999980616E-08 |
| Normal-vs-Stage2 |
4.698700E-03 |
| Normal-vs-Stage3 |
8.408500E-02 |
| Normal-vs-Stage4 |
1.028470E-02 |
| Stage1-vs-Stage2 |
6.756000E-01 |
| Stage1-vs-Stage3 |
2.718800E-01 |
| Stage1-vs-Stage4 |
7.222200E-01 |
| Stage2-vs-Stage3 |
5.624400E-01 |
| Stage2-vs-Stage4 |
5.434800E-01 |
| Stage3-vs-Stage4 |
3.639800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.05390000457473E-08 |
| Normal-vs-AfricanAmerican |
3.63899999999973E-06 |
| Normal-vs-Asian |
2.778700E-03 |
| Caucasian-vs-AfricanAmerican |
8.609000E-01 |
| Caucasian-vs-Asian |
8.508400E-01 |
| AfricanAmerican-vs-Asian |
7.665000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.96089955173795E-10 |
| Normal-vs-Female |
2.589800E-02 |
| Male-vs-Female |
6.815900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.036700E-04 |
| Normal-vs-Extreme_Weight |
3.38640000485668E-08 |
| Normal-vs-Obese |
9.363500E-04 |
| Normal-vs-Extreme_Obese |
5.061400E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.226600E-01 |
| Normal_Weight-vs-Obese |
4.322600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.213400E-01 |
| Extreme_Weight-vs-Obese |
1.013210E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.832000E-01 |
| Obese-vs-Extreme_Obese |
3.282000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.186000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.84940000003131E-06 |
| Normal-vs-Age(61-80Yrs) |
6.62249999283659E-09 |
| Normal-vs-Age(81-100Yrs) |
3.75679999997658E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.235200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.142970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.274500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.155200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.517240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.056600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.88290002981029E-09 |
| Normal-VS-Type2 PRCC |
2.44850000052921E-07 |
| Normal-VS-KIRP CIMP |
5.628200E-01 |
| Normal-VS-Unclassified PRCC |
1.559710E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.740400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.363800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.249760E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.195900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.627820E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.849620E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.56559998298889E-09 |
| Normal-vs-N1 |
1.722170E-01 |
| Normal-vs-N2 |
3.786000E-01 |
| N0-vs-N1 |
6.559900E-02 |
| N0-vs-N2 |
8.008000E-01 |
| N1-vs-N2 |
6.323000E-01 |
|
|
